CMO
Technology transfer and manufacturing from the client’s dossier.
COMPANY OVERVIEW · SEPTEMBER 2026
From formulation challenge to manufacturing programme.
Sikalias Pharmaceutical Laboratories SA · Two GMP manufacturing sites in Peristeri, Athens.
Three ways to work together
CDMO
Development, technical documentation and subsequent manufacturing, with an agreed regulatory pathway.
R&D materials
Project-based evaluation of APIs, excipients, extracts and functional ingredients.
Technical platform
Non-sterile oral liquids, topical and semisolid products, sprays and drops, hard capsules, tablets and powders. Low-humidity room below 10% RH, nitrogen capability on selected liquid lines, and integrated production and packaging flows.
Quality & qualification
Project-specific site selection, authorisation scope, technical transfer, stability and validation planning. QA provides the controlled quality package. Site 1 authorisation: EOF 5986 / 11 June 2026; see the quality page for the current GMP-documentation update.
Quality documentationContinue the conversation
info@sikalias.com · +30 210 572 0900 · https://sikalias.com/partners/
Site 0: 7 Kyklaminon, 12137 Peristeri
Site 1: 3–5 Stylianou Gonata, 12133 Peristeri